title: Transiently positive hepatitis B surface antigen after vaccination with the new hepatitis B vaccine HBV-AS04.
authors.forename: An
authors.initials: A
authors.lastname: Vanacker
authors.forename: Ignace
authors.initials: I
authors.lastname: Vandewiele
authors.forename: Johan
authors.initials: J
authors.lastname: Verbanck
authors.forename: Hans
authors.initials: H
authors.lastname: Schepkens
authors.forename: Gert
authors.initials: G
authors.lastname: De Schoenmakere
authors.forename: Emmanuel
authors.initials: E
authors.lastname: De Laere
authors.forename: Bart
authors.initials: B
authors.lastname: Maes
mesh_terms: D000368:Aged; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D017325:Hepatitis B Vaccines / Q000276:immunology*; D006801:Humans; D008050:Lipid A / Q000031:analogs & derivatives* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D013997:Time Factors
chemical_list: D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D008050:Lipid A; C530461:hepatitis B vaccine AS04